Monday, August 1st at 11am eastern
PPMD will host a webinar on Monday, August 1 at 11am eastern with PTC Therapeutics to discuss the latest news regarding Translarna. Craig McDonald will present the benefits of Translarna from emerging data and senior leadership from PTC will be on hand to answer questions regarding the path forward for the therapy with the FDA.
Pat Furlong: PPMD Founding President & CEO
Stuart W. Peltz, PhD: CEO, PTC Therapeutics
Mark E. Boulding: EVP and Chief Legal Officer, PTC Therapeutics
Craig McDonald, MD: UC Davis
Please submit questions in advance to email@example.com, with “PTC Webinar” in the subject line by noon on Thursday, 7/28.